학술논문

Patterns of cigarette, heated tobacco product, and nicotine vaping product use among Korean adults: Findings from the 2020 ITC Korea Survey.
Document Type
Academic Journal
Author
Lee S; Korea Center for Tobacco Control Research and Education, Seoul, Republic of Korea.; Xu SS; Department of Psychology, University of Waterloo, Waterloo, Canada.; Yan M; Department of Psychology, University of Waterloo, Waterloo, Canada.; Gravely S; Department of Psychology, University of Waterloo, Waterloo, Canada.; Quah ACK; Department of Psychology, University of Waterloo, Waterloo, Canada.; Seo HG; Korea National Cancer Center, Goyang, Republic of Korea.; Lim S; National Tobacco Control Center, Korea Health Promotion Institute, Seoul, Republic of Korea.; Cho SI; Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.; Kim Y; Korea National Cancer Center, Goyang, Republic of Korea.; Fong GT; Department of Psychology, University of Waterloo, Waterloo, Canada.; School of Public Health Sciences, University of Waterloo, Waterloo, Canada.; Ontario Institute for Cancer Research, Toronto, Canada.
Source
Publisher: European Publishing on behalf of International Society for the Prevention of Tobacco Induced Diseases (ISPTID) Country of Publication: Greece NLM ID: 101201591 Publication Model: eCollection Cited Medium: Internet ISSN: 1617-9625 (Electronic) Linking ISSN: 16179625 NLM ISO Abbreviation: Tob Induc Dis Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
Introduction: Non-combustible nicotine products (NCNPs), such as heated tobacco products (HTPs) and nicotine vaping products (NVPs) have gained a significant nicotine market share in South Korea. This descriptive study examined patterns of regular cigarette and NCNP use among South Korean adults.
Methods: Data were from the 2020 International Tobacco Control Korea Survey and included 4016 adults (aged ≥19 years) in the Republic of Korea who were regularly (at least weekly) using at least one NCNP (NVP/HTP, n=2117) and/or smoked cigarettes (n=3763) at the time of the survey. Weighted descriptive estimates were computed to assess respondents' nicotine product use among all respondents (exclusive, dual, or triple use). Thereafter, we identified sociodemographic characteristics associated with NCNP use (n=2117).
Results: Among Korean adults who were smoking cigarettes, 83.1% (95% CI: 81.6-84.6) did so exclusively, and 16.9% (95% CI: 15.4-18.4) smoked cigarettes and used NCNPs. Among those who used HTPs (n=1877), 14.9% (95% CI: 11.5-18.4) did so exclusively, 59.6% used HTPs and smoked cigarettes (95% CI: 55.4-63.1), 4.2% used HTPs and vaped (95% CI: 11.5-18.4), and 21.6% (95% CI: 18.9-24.2) used all three products. Of adults who used HTPs and smoked cigarettes, 86.6% smoked daily. Among those who vaped (n=865), 13.3% did so exclusively (95% CI: 9.4-17.1), 55.6% (95% CI: 49.6-61.5) vaped and smoked cigarettes, 5.1% (95% CI: 1.7-8.6) used HTPs and vaped, and 26.1% (95% CI: 22.1-30.1) used all three products. Of adults who vaped and smoked cigarettes, 82.4% (95% CI: 77.1-87.7) smoked daily.
Conclusions: Cigarettes remain the most commonly used nicotine product in South Korea, and among adults using heated tobacco and/or vaping products, the majority were also smoking. Research is urgently needed to assess whether adults who are using an NCNP are doing so to quit, or rather to complement their cigarette smoking.
Competing Interests: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. All the authors report that since the initial planning of the work they received support from the Republic of Korea National Health Promotion Fund and the Canadian Institutes of Health Research Foundation Grant (FDN-148477). S.S. Xu, M. Yan, S. Gravely and A.C.K. Quah report that in the past 36 months they received grants from the Canadian Institutes of Health Research (FDN-148477) and the US National Cancer Institute (P01 CA200512). G.T. Fong reports that in the past 36 months he has served as an expert witness or consultant for governments defending their country’s policies or regulations in litigation. Also, he reports that he has received a Senior Investigator Award from the Ontario Institute for Cancer Research (IA-004) and a grant from the US National Cancer Institute (P01 CA200512).
(© 2024 Lee S. et al.)